Recombinant DNA Advisory Committee - 12/3-4/92 
Jeffrey Fox, ASM News & Biotechnology 
Wayne Galbright, Public 
Victor Garcia, St. Jude Childrens Hospital 
Lisa Giglio, The Pink Sheet 
Scott Graham, University of Iowa 
Richard Gregory, Genzyme Corporation 
Mariann Grossman, University of Michigan 
Bill Guggino, Johns Hopkins Hospital 
Kurt Gunter, Food and Drug Administration 
Elie Hanania, MD Anderson Cancer Research Center 
Ingo Hartel, Georgetown University, Kennedy Center 
Mark Hausmann, National Museum of American History 
Russell Herndon, Genzyme Corporation 
David Holzman, Bioworld Today 
Susan Jenks, Journal of the National Cancer Institute 
Steve Josephs, Baxter Health Care 
Nancy Kan, Canji, Inc. 
Arifa Khan, Food and Drug Administration 
Michael Knowles, University of North Carolina 
Rebecca Kolberg, United Press International 
Hitoshi Kotani, Genetic Therapy, Inc. 
Maryann Krane, Genzyme Corporation 
Alex Kuta, Food and Drug Administration 
Karen Lee, National Museum of American History 
Pierre Lehn, Assistance Publique, Paris 
Melvin Long, Abbott Laboratories 
Alan McClelland, Genetic Therapy, Inc. 
Gerard McGarrity, Genetic Therapy, Inc. 
Bruce Merchant, Viagene 
Robert Moen, Genetic Therapy, Inc. 
Lisa Morris, Genetic Therapy, Inc. 
Richard Moscicki, Genzyme Corporation 
Rod Morrison, Canadian Cystic Fibrosis Foundation 
Stephen Mueller, Genetic Therapy, Inc. 
David Mulligan, Abbott Laboratories 
Hien Nguyen, National Museum of American History 
Philip Noguchi, Food and Drug Administration 
Jeffery O'Brian, Dupont-Merck Pharmaceuticals 
John Olsen, University of North Carolina 
Jeff Ostrove, Microbiological Association, Inc. 
Edward Otto, Genetic Therapy, Inc. 
Michel Perricaudet, National Center for Scientific Research, Paris 
Recombinant DNA Research, Volume 16 
[535] 
